← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2008Last known activity
Aug 1, 2023
Timeline
1890s
- Jun 1, 1895
Lallemand SAS— Founded
Drugs by trial phase (22 distinct, 32 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Anxiety Disorders
- Asthma
- Attention Deficit Disorder with Hyperactivity
- Body Weight
- Compulsive Personality Disorder
- Depression
- Depressive Disorder
- Diarrhea
- Dysentery
- Dyspepsia
- Emergencies
- Gastroenteritis
- Hyperalgesia
- Hyperkinesis
- Inflammation
- Irritable Bowel Syndrome
- Lung Diseases, Obstructive
- Major Depressive Disorder
- Obsessive-Compulsive Disorder
- Overweight
- Pulmonary Disease, Chronic Obstructive
- Stress, Psychological
- Substance Withdrawal Syndrome
- Syndrome
Recent trials (33)
- NCT05939336CollaboratorN/AAug 1, 2023
- NCT05524688CollaboratorPhase 1/Phase 2Jan 31, 2023
- NCT04511052CollaboratorPhase 2Nov 30, 2021
- NCT04473079Lead sponsorPhase 2/Phase 3Oct 16, 2020
- NCT04065503CollaboratorEarly Phase 1Sep 30, 2019
- NCT03867591CollaboratorN/AMar 22, 2019
- NCT03277157CollaboratorN/ADec 8, 2017
- NCT02962583CollaboratorPhase 2Jan 1, 2017
- NCT02893943CollaboratorN/AJan 1, 2017
- NCT04525040Lead sponsorN/ASep 14, 2016
- NCT02838043CollaboratorPhase 3Aug 1, 2016
- NCT02693314CollaboratorPhase 1Mar 1, 2016
- NCT02417454CollaboratorPhase 3Sep 1, 2015
- NCT02545634CollaboratorPhase 4Jun 1, 2015
- NCT02445560CollaboratorN/AJun 1, 2015
Details
- Founded
- Rexdale, ON, CA Jun 1, 1895
- Last known activity
- Aug 1, 2023